CN Bio appoints Deepak Singh as Vice President of Sales and Marketing
March 14, 2023
Cambridge, UK: CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has today announced that is has appointed Deepak Singh as Vice President of Sales and Marketing. Deepak’s appointment supports the Company’s next phase of commercial development as it expands international operations, product research and development and sales in [...]
Molecular Assemblies Ships First Enzymatically Synthesized Oligonucleotides
March 14, 2023
SAN DIEGO – Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced it has shipped the first enzymatically synthesized oligonucleotides to top biotechnology, academic, and synthetic biology researchers, delivered as part of a key customer program. The ability to quickly deliver long, highly pure DNA using a proprietary Fully Enzymatic [...]
March 14, 2023
CeGaT is expanding its NGS laboratory with the brand new NovaSeq™ X Plus from Illumina. This strategically important step enables CeGaT to serve the growing global demand for sequencing services and molecular genetic analysis and to make Illumina’s latest sequencing platform available to its customers. On Monday, October 3rd, 2022, Illumina unveiled its latest advancement [...]
March 14, 2023
NOTTINGHAM, England --Albumedix Ltd ('Albumedix'), Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc ('Heartseed'), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin® is a critical component of Heartseed's HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing. Recombumin, an animal and human origin free [...]
Arima Genomics Announces Appointments to its Board of Directors
March 14, 2023
Carlsbad, Calif. – Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians seeking to improve human health, today announced the appointment of diagnostics industry veterans John Palma, PhD, and Don Hardison to its Board of Directors. In addition to Dr. Palma and Mr. Hardison, the Arima [...]
March 14, 2023
Peabody, MA – Petrochemical analysis just got a little bit easier with the introduction of JEOL’s AccuTOF™ GC Alpha. A leader in the mass spectrometry space for over 60 years, this 6th-generation high resolution time-of-flight mass spectrometer (HRTOFMS) features increased mass resolving power (R=30,000), improved mass accuracy (≤ 1ppm), and multiple soft ionization sources, making it [...]
60 YEARS OF MASS SPECTROMETRY INNOVATION: JEOL Introduces The Ultimate General-Purpose GC-QMS
March 14, 2023
Peabody, MA – JEOL USA, Inc, a leader in the mass spectrometry space for over 60 years, has once again reimagined their single quadrupole instrument to meet the evolving needs of the scientific community. Officially termed the JMS-Q1600GC UltraQuad™ SQ-Zeta, this GC-Quadrupole Mass Spectrometer is equipped with high-performance capabilities for a wide variety of measurement and [...]
GeminiBio Appoints Industry Veteran Cory Stevenson as Executive Chairman
March 14, 2023
Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson as Executive Chairman of the Board of Directors. Fort Lauderdale, Florida and Sacramento, California – Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company [...]
Illumina Responds to Icahn Partners’ Nomination of Directors
March 13, 2023
SAN DIEGO -- Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for election to the Board [...]
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
March 13, 2023
Transforms into new Life Sciences and Diagnostics company WALTHAM, Mass. -- PerkinElmer Inc. (NYSE: PKI), today announced that it has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital, a growth-oriented investment firm. The resulting new, high-growth Life Sciences and Diagnostics business, focused on developing and delivering novel scientific [...]

